Growth Metrics

Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -114.28%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -674.01%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -122.45%
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn 172.84%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 172.84%
Dec 31, 2025 -92.54%
Sep 30, 2025 -253.12%
Jun 30, 2025 -149.31%
Mar 31, 2025 37.85%
Dec 31, 2024 -289.87%
Sep 30, 2024 222.83%
Jun 30, 2024 -199.85%
Mar 31, 2024 -5,538.82%
Dec 31, 2023 131.38%
Sep 30, 2023 -3,887.46%
Jun 30, 2023 3.84%
Mar 31, 2023 87.07%
Dec 31, 2022 -3,114.21%
Sep 30, 2022 117.16%
Jun 30, 2022 98.49%
Mar 31, 2022 -105.06%
Dec 31, 2021 -113.78%
Sep 30, 2021 90.41%
Jun 30, 2021 -697.71%
Mar 31, 2021 1,326.92%
Dec 31, 2020 146.03%
Sep 30, 2020 -75.15%
Jun 30, 2020 -27,995.72%
Mar 31, 2020 -136.18%
Dec 31, 2019 -497.71%
Sep 30, 2019 16.73%
Jun 30, 2019 98.62%
Mar 31, 2019 418.42%
Dec 31, 2018 225.45%
Sep 30, 2018 5.71%
Jun 30, 2018 -532.10%
Mar 31, 2018 -1,359.12%
Dec 31, 2017 -1,614.79%
Sep 30, 2017 86.72%
Jun 30, 2017 85.38%
Mar 31, 2017 70.20%
Dec 31, 2016 44.79%
Sep 30, 2016 -29,576.95%
Jun 30, 2016 -1,615.75%
Mar 31, 2016 -165.57%
Dec 31, 2015 76.25%
Sep 30, 2015 93.79%
Jun 30, 2015 8.46%
Mar 31, 2015 101.91%
Sep 30, 2014 -531.66%
Jun 30, 2014 -31.20%
Mar 31, 2014 -14,756.48%
Sep 30, 2013 -251.08%
Jun 30, 2013 98.22%
Mar 31, 2013 -107.81%
Dec 31, 2012 232.91%
Sep 30, 2012 72.48%
Jun 30, 2012 -68,344.15%
Mar 31, 2012 7,027.62%
Dec 31, 2011 -5,793.89%
Sep 30, 2011 -1,590.07%